Drug Type Gene therapy |
Synonyms PHVEGF165 |
Target |
Action agonists |
Mechanism VEGFR agonists(Vascular endothelial growth factor receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Neuropathies | Phase 2 | - | - | |
Diabetic Neuropathies | Phase 2 | - | - |
Phase 3 | Chronic Limb-Threatening Ischemia diabetic retinopathy | history of malignancy | - | Naked Plasmid Encoding Vascular Endothelial Growth Factor (phVEGF165) | wwyvwxbiuf(bsagczrqrg) = Complications were limited to transient lower extremity edema in three patients uybplxdrix (qtsjqsydwq ) View more | Positive | 01 May 2002 |